New! Sign up for our free email newsletter.
MALMÖ, SE / ACCESS Newswire / June 30, 2026 / Ascelia Pharma AB (publ) (STO:ACE), a biotech company focused on improving the life of people living with rare cancer conditions, today announced the fili ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果